This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Italfarmaco Spa. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Chiara Ripamonti: Innovator in Selective HDAC6 Inhibitors
Introduction
Chiara Ripamonti is a notable inventor based in Monza, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective HDAC6 inhibitors. Her work focuses on novel compounds that have the potential to impact therapeutic strategies.
Latest Patents
Chiara holds a patent for "Selective HDAC6 inhibitors." This invention relates to novel benzohydroxamic compounds of formula (I) and (II) and pharmaceutically acceptable salts, isomers, and prodrugs thereof. These compounds exhibit a high selective inhibitory activity against the histone deacetylase 6 (HDAC6) enzyme, which is crucial for various biological processes.
Career Highlights
Chiara is currently associated with Italfarmaco Spa, a company known for its commitment to research and development in the pharmaceutical sector. Her role involves leveraging her expertise to advance innovative solutions in medicine.
Collaborations
Chiara collaborates with talented professionals, including Barbara Vergani and Gianluca Caprini. These partnerships enhance the research and development efforts at Italfarmaco Spa.
Conclusion
Chiara Ripamonti is a pioneering inventor whose work on selective HDAC6 inhibitors showcases her dedication to advancing pharmaceutical innovations. Her contributions are poised to make a significant impact in the field of medicine.